Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2. [electronic resource]
- EMBO molecular medicine Jun 2015
- 770-87 p. digital
Publication Type: Journal Article
1757-4684
10.15252/emmm.201404193 doi
Angiopoietin-1--metabolism Animals Breast Neoplasms--drug therapy Cell Line, Tumor Endothelial Cells--drug effects Mice Neoplasm Metastasis--prevention & control Permeability--drug effects Receptor, TIE-2--agonists Transendothelial and Transepithelial Migration--drug effects